Moreover, recently it has been reported that macrophage-targeted delivery of small interference RNA against CCR2 inhibited ATM recruitment and accumulation in adipose tissue, thus reducing the downstream effects of obesity-induced inflammation [72]. The gene discussed is CCR2; the disease is obesity due to melanocortin 4 receptor deficiency.